Common Contracts

AMENDED AND RESTATED MARKETING AGREEMENT

Marketing Agreement • May 5th, 2020 • Michigan

• Contract Type
  Marketing Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Michigan

This Amended and Restated Marketing Agreement (the "Agreement") is made effective as of the 5th day of November 2008 (the "Effective Date"), by and between Emergent BioDefense Operations Lansing Inc. (formerly known as BioPort Corporation), a Michigan corporation having offices at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 ("Emergent") and Intergen N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles ("Intergen") (Emergent and Intergen each a "Party" and collectively the "Parties").

AMENDED AND RESTATED MARKETING AGREEMENT

Marketing Agreement • March 6th, 2009 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Michigan

• Contract Type
  Marketing Agreement
• Filed
  March 6th, 2009
• Company
  Emergent BioSolutions Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Michigan

This Amended and Restated Marketing Agreement (the "Agreement") is made effective as of the 5th day of November 2008 (the "Effective Date"), by and between Emergent BioDefense Operations Lansing Inc. (formerly known as BioPort Corporation), a Michigan corporation having offices at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 ("Emergent") and Intergen N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles ("Intergen") (Emergent and Intergen each a "Party" and collectively the "Parties").

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions AMENDED AND RESTATED MARKETING AGREEMENT

Marketing Agreement • May 7th, 2008 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Michigan

• Contract Type
  Marketing Agreement
• Filed
  May 7th, 2008
• Company
  Emergent BioSolutions Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Michigan

This Amended and Restated Marketing Agreement (the “Agreement”) is made effective as of the 5th day of November 2007 (the "Effective Date"), by and between Emergent BioDefense Operations Lansing Inc. (formerly known as BioPort Corporation), a Michigan corporation having offices at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 (“Emergent”) and Intergen N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles (“Intergen”) (Emergent and Intergen each a “Party” and collectively the “Parties”).